28
Participants
Start Date
March 31, 2008
Primary Completion Date
March 31, 2009
Study Completion Date
June 30, 2010
Panitumumab
The first infusion of panitumumab will occur on Cycle 1 Day 4. On Cycle 2 Day 1, panitumumab will be administered on the same day as irinotecan and every 2 weeks thereafter.
Irinotecan
The first infusion of irinotecan will occur on Cycle 1 Day 1. Irinotecan will be administered on the same day as panitumumab on Cycle 2 Day 1 and every 2 weeks thereafter.
Research Site, Philadelphia
Research Site, Chapel Hill
Research Site, Nashville
Research Site, Billings
Research Site, Billings
Research Site, Chapel Hill
Research Site, Philadelphia
Research Site, Nashville
Research Site, Vancouver
Research Site, Toronto
Research Site, Vancouver
Research Site, Toronto
Lead Sponsor
Amgen
INDUSTRY